What Is New in Antibiotic Therapy in Community-Acquired Pneumonia? An Evidence-Based Approach Focusing on Combined Therapy

被引:0
|
作者
Simone Gattarello
机构
[1] Vall d’Hebron University Hospital,Critical Care Department
来源
关键词
Community-acquired pneumonia; Antibiotic treatment; Monotherapy; Combined therapy; Guidelines;
D O I
暂无
中图分类号
学科分类号
摘要
Despite all published literature, controversies remain about the optimal antibiotic treatment in community-acquired pneumonia. The most debated issue is whether it is necessary to empirically start one or two antibiotics, i.e. whether or not to cover atypical agents. A review of the literature published from 2005 to present was completed, searching for new insights in antibiotic treatment in community-acquired pneumonia (CAP) focusing on monotherapy versus combined therapy. Forty-one articles were identified enrolling outpatients, and patients admitted to the ward and to the intensive care unit: 11 were meta-analyses, 8 clinical trials and 22 observational—prospective and retrospective—studies. Although controversies remain in the treatment of CAP, the use of combination therapy seems to be associated with a lower mortality in case of severe CAP that requires intensive care unit (ICU) admission, especially when a beta-lactam–macrolide association is delivered. Moreover, combination therapy is associated with better outcomes—although not always with a lower mortality—in cases of non-ICU patients with risk factors for a poor outcome, bacteraemic pneumococcal pneumonia and high suspicion of infection by atypical agents. In this setting, it appears that the best choice of treatment may be a beta-lactam–macrolide regimen.
引用
收藏
相关论文
共 50 条
  • [1] What Is New in Antibiotic Therapy in Community-Acquired Pneumonia? An Evidence-Based Approach Focusing on Combined Therapy
    Gattarello, Simone
    [J]. CURRENT INFECTIOUS DISEASE REPORTS, 2015, 17 (10)
  • [2] Evidence-based medicine: Empiric antibiotic therapy in community-acquired pneumonia
    Read, RC
    [J]. JOURNAL OF INFECTION, 1999, 39 (03) : 171 - 178
  • [3] Antibiotic therapy for community-acquired pneumonia
    Mandell, LA
    [J]. CLINICS IN CHEST MEDICINE, 1999, 20 (03) : 589 - +
  • [4] Treatment Guidelines for Community-acquired Pneumonia in Korea: An Evidence-based Approach to Appropriate Antimicrobial Therapy
    Song, Jae-Hoon
    Jung, Ki-Suck
    Kang, Moon Won
    Kim, Do Jin
    Pai, Hyunjoo
    Suh, Gee Young
    Shim, Tae Sun
    Ahn, Joong Hyun
    Ahn, Chul Min
    Woo, Jun Hee
    Lee, Nam Yong
    Lee, Dong-Gun
    Lee, Mi Suk
    Lee, Sang Moo
    Lee, Yeong Seon
    Lee, Hyukmin
    Chung, Doo Ryeon
    [J]. INFECTION AND CHEMOTHERAPY, 2009, 41 (03): : 133 - 153
  • [5] Treatment Guidelines for Community-acquired Pneumonia in Korea: An Evidence-based Approach to Appropriate Antimicrobial Therapy
    Song, Jae-Hoon
    Jung, Ki-Suck
    [J]. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2010, 53 (01): : 20 - 42
  • [6] Advances in antibiotic therapy for community-acquired pneumonia
    Viasus, Diego
    Garcia-Vidal, Carolina
    Carratala, Jordi
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2013, 19 (03) : 209 - 215
  • [7] Antibiotic therapy in children with community-acquired pneumonia
    Korppi, Matti
    [J]. ACTA PAEDIATRICA, 2021, 110 (12) : 3246 - 3250
  • [8] Antibiotic Therapy for community-acquired Pneumonia in Childhood
    Gappa, M.
    [J]. PNEUMOLOGE, 2014, 11 (04): : 345 - 346
  • [9] Combination antibiotic therapy for community-acquired pneumonia
    Jesus Caballero
    Jordi Rello
    [J]. Annals of Intensive Care, 1
  • [10] Combination antibiotic therapy for community-acquired pneumonia
    Caballero, Jesus
    Rello, Jordi
    [J]. ANNALS OF INTENSIVE CARE, 2011, 1